
Global Health Security Index
The GHS Index highlights individual country needs, boost compliance with international standards, and create better understanding of global capabilities to prevent, detect, and respond to biological threats.
The dangers are real.
We can create a safer world.
NTI offers solutions.
As COVID-19 has vividly demonstrated, the risk of a catastrophic biological event is magnified by an increasingly interconnected world, challenged by political instability, urbanization, climate change, and new technologies that make it easier, cheaper, and faster to create and engineer pathogens.
228 Million+ Global cases of COVID-19
38.9 The average 2021 GHS Index score, showing that global preparedness for epidemics and pandemics is fundamentally weak
170+ The number of experts participating in NTI | bio’s Global Biosecurity Dialogue across 40+ countries and organizations.
Addressing biological threats is a shared responsibility between governments and the private sector. NTI | bio fosters new thinking, tests solutions, and advocates for change.
The GHS Index highlights individual country needs, boost compliance with international standards, and create better understanding of global capabilities to prevent, detect, and respond to biological threats.
Advances in biotechnology outpace national governments’ ability to provide needed oversight to prevent accidents or deliberate misuse of dangerous biological agents.
Reducing biological risk and enhancing global security
Preventing global catastrophic biological risks (GCBRS)
Safeguarding modern bioscience and biotechnology so it can advance and flourish safely and responsibly
Establishing an international Common Mechanism for DNA Synthesis Screening
Cultivating the Next Generation of Global Biosecurity Leaders
Rapidly assessing origins of high-consequence global biological events
Establishing stronger norms and practices to prevent accidents, misuse, and other adverse outcomes of life science research
NTI | bio hosted an event on Capitol Hill to discuss how Congress and other key decisionmakers can take action to provide necessary oversight to safeguard biotechnologies, without stifling innovation in the field.
Education Center